French enforcer aims to shake up pharma market
France’s antitrust agency has launched a second inquiry of the national pharmaceutical market, after policymakers largely ignored its first round of recommendations intended to encourage liberalisation.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.